Elicio Therapeutics, Inc
(NASDAQ: ELTX)
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
8.380 -
-0.020
(-0.24%)
价格区间
8.050 - 8.700
(8.07%)
开盘
8.400
昨收
8.400
买
8.260
买盘
225
卖
8.360
卖盘
100
成交量
40,949
成交额
287,475
注释
-
数据延迟。最后一次更新12 Feb 2026 23:56.
数据提供商
查看所有活动
Loading Chart...
Please login to view stock data and analysis
